Health TrialsbyHealthPanel

Speech Treatment for Minimally Verbal Children With ASD and CAS

ConditionsDevelopmental Verbal DyspraxiaAutism Spectrum Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-18
SponsorMGH Institute of Health Professions

About this trial

Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Meets criteria for Autism Spectrum Disorder

Able to correctly repeat at least 2 syllables

Meets criteria for Childhood Apraxia of Speech

Lives in an environment where child is exposed to English at least 50% of the time

Disqualifiers

Poorly controlled seizures

Factors such as blindness or deafness that contribute to minimally verbal status

Lives in an environment where English is not spoken at least 50% of the time

Child experiences behavioral challenges that preclude participation in the study

Trial design

Design model

Single group

Treatments tested in this trial

  • CAS Treatment for Minimally Verbal Children with Autism

    Behavioral

    Treatment involves principles of motor learning embedded in a naturalistic developmental milieu

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: CAS Treatment for MV ASDExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Attempts Correct

Number or percent of target items that were produced correctly

Time frame
5 weeks
2

Phonemes Correct

Number or percent of phonemes (vowels, consonants) in the target items that were produced correctly

Time frame
5 weeks

Secondary outcomes

1

Lip aperture movement variability

Amount of variability in lip opening area during production of multiple attempts at the same target

Time frame
5 weeks
2

Phoneme distinctiveness

Acoustic distinctiveness of different phonemes

Time frame
5 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

MGH Institute of Health Professions

Lead sponsor

Source ClinicalTrials.gov
Apply now